CMS Reconsiders Medicare Coverage For Esophageal Blood Flow Monitor
This article was originally published in The Gray Sheet
Executive Summary
CMS is reconsidering Medicare coverage for a probe that uses the Doppler effect to measure the volume of blood being pumped through the body in sedated patients
You may also be interested in...
Coverage for ultrasound diagnostic
CMS 1proposes Feb. 26 to remove national non-coverage of cardiac output Doppler monitoring, noting "there is sufficient evidence to conclude that esophageal Doppler monitoring of cardiac output for ventilated patients in the ICU and operative patients with a need for intra-operative fluid optimization is reasonable and necessary." CMS was asked to reconsider its existing non-coverage policy by UK-based Deltex Medical Group, whose CardioQ esophageal Doppler monitor was cleared by FDA in 2003 (2"The Gray Sheet" Sept. 11, 2006, p. 12). Comments on the proposal are due March 28, with a final decision expected in May...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”